We are live on ! Find out more
SNTI icon

Senti Biosciences Holdings

24 hedge funds and large institutions have $16.6M invested in Senti Biosciences Holdings in 2022 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 5 increasing their positions, 7 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

25% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 4

4% more funds holding

Funds holding: 23 → 24 (+1)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

2.5% less ownership

Funds ownership: 30.78% → 28.28% (-2.5%)

29% less repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 7

53% less capital inflows, than outflows

Capital inflows: $2.04M | Capital outflows: $4.36M

Holders
24
Holders Change
+1
Holders Change %
+4.35%
% of All Funds
0.38%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
5
Increased
5
Reduced
7
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

SNTI Hedge Fund Activity: Q4 2022 in Review

24 of the 6,238 institutional investors tracked by Wall St. Rank reported a position in Senti Biosciences Holdings (SNTI) for Q4 2022, worth a combined $16.6M — down 40% from $27.8M a quarter earlier.

Buyers outnumbered sellers: 5 funds opened new SNTI positions and 4 closed out — a net gain of 1 holder — while 5 added to existing stakes and 7 trimmed.

The largest buyer was Vanguard Group, opening a new position worth an estimated $1.26M. The largest seller was Artal Group, cutting an estimated $2.44M.

  • 24 institutional investors held Senti Biosciences Holdings (SNTI) as of Q4 2022, up from 23 in Q3 2022.
  • Funds reported $16.6M of Senti Biosciences Holdings stock for Q4 2022, down 40% quarter-over-quarter.
  • 5 funds opened new Senti Biosciences Holdings positions in Q4 2022 and 4 closed out, a net change of +1 holder.
  • The largest Senti Biosciences Holdings buyer in Q4 2022 was Vanguard Group, an estimated $1.26M added.
  • The largest Senti Biosciences Holdings seller in Q4 2022 was Artal Group, an estimated $2.44M sold.

Based on aggregated 13F filings for Q4 2022.